Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2011-08-30
2011-08-30
Boesen, Agnieszka (Department: 1648)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S133100, C424S134100, C424S135100, C424S139100, C424S149100, C435S070210
Reexamination Certificate
active
08007792
ABSTRACT:
New conformational antibodies are directed against HCV and more particularly to monoclonal antibodies. Described compositions of particles are liable to be recognized by the antibodies, as are pharmaceutical compositions containing them. Also described are HCV enveloped subviral particles or purified HCV enveloped complete viral particles, and the processes for preparing them.
REFERENCES:
patent: 7524650 (2009-04-01), Petit et al.
patent: WO 91/15574 (1991-10-01), None
patent: WO 02/057314 (2002-07-01), None
Owens et al. (Journal of Immunological Methods, 1994, vol. 168, p. 149-165).
Cocquerel Laurence et al:, “Recognition of native hepatitis C virus E1E2 heterodimers by a human monoclonal antibody.”, Journal of Virology, vol. 77, No. 2, Jan. 20, 2003, pp. 1604-1609, XP002256295, ISSN:0022-538X, p. 1604-, right-hand column, line 6-plage 1605, right-hand coluimn, line 12.
Choukhi Amelie et al:, “Characterization of aggregates of hepatitis C virus glycoproteins.”, Journal of General Virology, vol. 80, No. 12, Dec. 1999, pp. 3099-3107, XP002256296, ISSN: 0022-1317, p. 3101, left-hand column, line 24-right-hand column, line 12; figure 1.
Deleersnyder V et al: “Formation of Native Hepatitis C Virus Glycoprotein Complexes”, Journal of Virology, The American Society for Microbiology, US, vol. 71, No. 1, 1997, pp. 697-704, XP002030792, ISSN: 0022-538X.
Fournillier A et al:, “Expression of noncovalent hepatitis C virus envelope E1-E2 complexes is not required for the induction of antibodies with neutralizing properties following DNA immunization”, Journal of Virology, The American Society for Microbiology, US,, vol. 73, No. 9, Sep. 1999, pp. 7497-7504, XP002191425, ISSN: 0022-538X, abstract.
Seong Young Rim et al: “Immunogenicity of the E1E2 proteins of hepatitis C virus expressed by recombinant adenoviruses.”, Vaccine, vol. 19, No. 20-22, 2001, pp. 2955-2964, XP0022569297, ISSN: 0264-410X, abstract.
Pumeechockchai W et al:, “Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: Implications for virus clerance by antibody”, Journal of Medical Virology, vol. 68. No. 3, Nov. 2002, pp. 335-342, XP008025913, ISSN: 0146-6615, p. 335, left-hand column, p. 337, left-hand column-right hand column, line 10, p. 340, left-hand column, paragraph 2-p. 341, rightr-hand column, last paragraphj.
Delpuech Oona et al:, “The hepatitis C virus (HCV) induces a long-term increase of interleukin-10 production b y human CD4+ T cells (H9)”, European Cytokine Network, vil. 12, No. 1, Mar. 2001, pp. 70, left-hand column, last paragraph-right-hand column, paragraph 1.
Bartosch Birke et al: “Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes.”, Journal of Experimental Medicine, vol. 197. No. 5, Mar. 3, 2003 92003-03-03), pp. 633-642, XP002267934, ISSN: 0022-1007, p. 633, left-hand column, line 1 right-hand column, line 1; figure 2.
Grant P R et al:, “Quantification of HCV RNA levelsw and detection of core antigen in donations before seroconversion”, Transfusion (Bethesda), vol. 42, No. 8, Aug. 2002, pp. 1032-1036, XP001174198, ISSN: 0041-1132, p. 1034, right-hand column, line 16-line 24.
Lechmann et al., Hepatology, 2001, vol. 34, p. 417-423.
Journal of Biochemical Chemistry, Nov. 2003, vol. 278, p. 44385-44392.
Jolivet-Reynaud Colette
Petit Marie-Anne
Trepo Christian
BioMerieux SA
Boesen Agnieszka
Inserm
Young & Thompson
LandOfFree
Antibodies directed against hepatitis C virus E1E2 complex,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies directed against hepatitis C virus E1E2 complex,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies directed against hepatitis C virus E1E2 complex,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2674699